Triple

T6301598
Position Surface form Disambiguated ID Type / Status
Subject Delta Cancri E141267 entity
Predicate isInConstellation P32060 FINISHED
Object Cancer E137795 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer | Statement: [Delta Cancri, isInConstellation, Cancer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cancer
Context triple: [Delta Cancri, isInConstellation, Cancer]
  • A. Cancer chosen
    Cancer is the fourth astrological sign of the zodiac, symbolized by the Crab and traditionally associated with emotional sensitivity, intuition, and nurturing qualities.
  • B. Cancer Research
    Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
  • C. Cancer Programs
    Cancer Programs is a set of initiatives and standards by the American College of Surgeons focused on improving the quality and outcomes of cancer care across accredited institutions.
  • D. Cancer Discovery
    Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
  • E. Division of Cancer Treatment and Diagnosis
    The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008cf0ad4819095def81e2bd42f9f completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c0645bb41481909294b06e2b3e1845 completed March 22, 2026, 9:51 p.m.
NED1 Entity disambiguation (via context triple) batch_69c7421871888190aab99c6c5f6c147d completed March 28, 2026, 2:51 a.m.
Created at: March 22, 2026, 4:27 p.m.